Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice

Journal of Neuroimmunology

Volumn 116, Issue 2, 2001, Pages 147-155

  Roy, Sabita ^a   Wang, Jing Hua ^a   Balasubramanian, Sudha ^a   Sumandeep, ^a   Charboneau, Rick ^a   Barke, Roderick ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Corticosterone; Dexamethasone; Morphine; Mu opioid receptor knockout; T cell; Thymus

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BINALTORPHIMINE; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DEXAMETHASONE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALTREXONE; NORBINALTORPHIMINE; PLACEBO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DOSE RESPONSE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPHOCYTE DIFFERENTIATION; MORPHINE ADDICTION; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; TISSUE DISTRIBUTION;

ADRENOCORTICOTROPIC HORMONE; ANALGESICS, OPIOID; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CORTICOSTERONE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; MICE, KNOCKOUT; MORPHINE; ORGAN SIZE; PITUITARY GLAND; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; THYMUS GLAND;

EID: 0035363736     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00299-5     Document Type: Article

References (43)

1. Immunosuppressive effects of chronic morphine treatment
2. Role of the adrenal cortical activation in the immunosupressive effects of chronic morphine treatment
3. Cytokine reversal of morphine-induced suppression of the antibody response
4. Molecular cloning and functional expression of a u opioid receptor from rat brain
5. Mu opioid receptor gene expression in immune cells
6. Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations
7. Evidence for B-adrenergic receptor involvement in the immunomodulatory effects of acute morphine treatment in rats
8. Macrophage-derived nitric oxide is involved in the depressed con A-responsiveness of splenic lymphocytes from rats administered morphine in vivo
9. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats
10. Noradrenergic and peptidergic innervation of lymphoid tissue
11. Acute immunosuppressive effects of morphine: Lack of involvement of pituitary and adrenal factors
12. Changes in hypothalamic paraventricular nucleus catecholaminergic activity afteracute and chronic morphine administration
13. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
14. The mu1, mu2 delta kappa opioid receptor binding profiles of methadone stereoisomers and morphine
15. Effects of morphine and U50,488H on neurochemical activity of the hypothalamic noradrenergic neurons and pituitary adrenal neurons
16. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: Implication of alpha(1)- and alpha (2) adrenoreceptors
17. Mu opioid receptor knockout in mice: Effects on ligand-induced anagesia and morphine lethality
18. Opioid binding to cells of the immune system in drugs of abuse and the immune system
19. 3-opiate receptors
20. Properties of mu 3 opiate alkaloid receptors in macrophages, astrocytes and HL promyelocytic leukemia cells
21. Opiate receptors on lymphocytes and platelets in man
22. Immunoregulation by opiate peptides
23. Evidence for central opioid receptors in the immunomodulatory effects of morphine: Review of potential mechanism(s) of action
24. Morphine's immunologic and analgesic effects
25. Involvement of central but not delta or kappa receptors in immunomodulation
26. Effects of opioids on the immune system
27. 3H-Morphine binding is enhanced by IL-1 stimulated thymocyte proliferation
28. 3H-Morphine binding to Interleukin-1 activated thymocytes
29. Mu-receptor knockout mice: The role of Mu-opioid receptor in immune functions
30. Mu-receptor knockout mice: The role of mu-opioid receptor in gastrinestinal transit
31. Complementary cloning of a mu-opioid receptor from rat peritoneal macrophage
32. Evidence for opioid receptors on cells involved in host defense and the immune system
33. Morphine-induced suppression of natural killer cell activity is mediated by the adrenal gland
34. Opioid peptides and opioid receptors in cells of the immune system
35. The presence of the mu3 opiate receptor in invertebrate neural tissues
36. Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues
37. Endogenous morphine
38. Immunomodulation mediated by microinjection of morphine into the peraueductal gray matter of the mesencephalon
39. Mu opiate receptor: cDNA cloning and expression
40. The periaqueductal grey matter mediates opiate-induced-immunosupression
41. Morphine tolerance, physical dependence, and synthesis of brain 5-HT